SeaCrest Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History

SeaCrest Wealth Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,125	Closed	-$67K	–	1438
2022 Q2	$67K	Buy	+1,125	New	+$92.4K	0.01%	1013
2019 Q2	–	Sell	-600	Closed	-$38K	–	1719
2019 Q1	$38K	Buy	600 +500	+500%	+$26.3K	0.01%	1043
2018 Q4	$4K	Sell	100 -500	-83%	-$17.7K	﹤0.01%	1778
2018 Q3	$26K	Hold	600	–	–	﹤0.01%	1273
2018 Q2	$13K	Buy	+600	New	+$7.38K	﹤0.01%	1526

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SeaCrest Wealth Management's TNDM Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 1,125 shares — an estimated $67K sold.

SeaCrest Wealth Management first reported a position in TNDM in Q2 2018 and held it in 5 quarters. The position peaked at $67K in Q2 2022. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

SeaCrest Wealth Management reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
SeaCrest Wealth Management sold 1,125 Tandem Diabetes Care shares in Q3 2022, an estimated $67K.
SeaCrest Wealth Management first reported a position in Tandem Diabetes Care in Q2 2018 and held it in 5 quarters.
SeaCrest Wealth Management's Tandem Diabetes Care position peaked at $67K in Q2 2022.
299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.